Spondyloepimetaphyseal dysplasia with elevated plasma lysosomal enzymes caused by homozygous variant in MBTPS1. Issue 7 (18th May 2020)

• Record Type: Journal Article
• Authors: Carvalho, Daniel R.; Speck‐Martins, Carlos E.; Brum, Jaime M.; Ferreira, Carlos R.; Sobreira, Nara L. M.
• Is Part Of: American journal of medical genetics. Volume 182:Issue 7(2020)
• Page Start: 1796
• Page End: 1800
• Publication Date: 2020-05-18
• Subjects: cataract -- MBTPS1 -- retromicrognathia -- site‐1 protease (S1P) -- spondylepimetaphyseal dysplasia; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.61614
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Variants in MBTPS1 (membrane‐bound transcription factor peptidase, site 1) encoding the protein convertase site‐1 protease (S1P) were recently reported in a single individual with skeletal dysplasia and elevated plasma lysosomal enzymes. Here, we report the second individual with this newly described autosomal recessive spondyloepiphyseal dysplasia (OMIM #618392), presenting severe growth retardation, cataract and dysmorphic features, mainly retromicrognathia. Epilepsy and craniosynostosis were novel findings in our proband. She was found to be homozygous for a novel nonsense variant p.Trp983Ter in MBTPS1 . In addition, she had normal levels of lysosomal enzyme activity in leukocytes but elevated levels in plasma. Our description confirms the existence of this new skeletal dysplasia and expands the phenotype and genotype of the disease.